{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:58:46Z","timestamp":1793948326279,"version":"4.8.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.anai.2025.03.022","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T02:50:10Z","timestamp":1743648610000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence of mast cell activation disorders and hereditary alpha tryptasemia among patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: A systematic review"],"prefix":"10.1016","volume":"135","author":[{"given":"Matthew","family":"Farley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Estrada-Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Gansert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayne","family":"Voelker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5754-6130","authenticated-orcid":false,"given":"Alexei","family":"Gonzalez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.anai.2025.03.022_bib0001","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2018.11.059","article-title":"Postural orthostatic tachycardia syndrome: JACC focus seminar","volume":"73","author":"Bryarly","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.anai.2025.03.022_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.007960","article-title":"Sinus tachycardia: a multidisciplinary expert focused review","volume":"15","author":"Mayuga","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.c.31552","article-title":"The 2017 international classification of the Ehlers-Danlos syndromes","volume":"175","author":"Malfait","year":"2017","journal-title":"Am J Med Genet C"},{"issue":"3","key":"10.1016\/j.anai.2025.03.022_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2014.03.007","article-title":"Mast cell activation disorders","volume":"2","author":"Akin","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2025.03.022_bib0005","first-page":"258","article-title":"The clinical features of hereditary alpha-tryptasemia\u2014implications for interdisciplinary practice","volume":"121","author":"vonBubnoff","year":"2024","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"11","key":"10.1016\/j.anai.2025.03.022_bib0006","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1016\/j.jaip.2021.06.011","article-title":"Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review","volume":"9","author":"G\u00fclen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.03.022_bib0007","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.03.022_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"11","key":"10.1016\/j.anai.2025.03.022_bib0009","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: A consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"issue":"7","key":"10.1016\/j.anai.2025.03.022_bib0010","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.anai.2025.03.022_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021002","article-title":"Mast cell activation disorder and postural orthostatic tachycardia syndrome: a clinical association","volume":"10","author":"Kohno","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0012","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/joim.12895","article-title":"The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey","volume":"286","author":"Shaw","year":"2019","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0013","doi-asserted-by":"crossref","first-page":"AB67","DOI":"10.1016\/j.jaci.2018.12.204","article-title":"Ehlers-Danlos syndrome is associated with Idiopathic urticaria - a retrospective study","volume":"143","author":"Szalewski","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0014","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaccas.2021.01.009","article-title":"Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience","volume":"3","author":"Johansson","year":"2021","journal-title":"JACC Case Rep"},{"issue":"suppl","key":"10.1016\/j.anai.2025.03.022_bib0015","first-page":"S670","article-title":"Small intestinal bacterial overgrowth is common in mast cell activation syndrome","volume":"114","author":"Weinstock","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0016","doi-asserted-by":"crossref","first-page":"A5055","DOI":"10.1016\/j.chest.2023.07.3275","article-title":"Dyspnea on exertion secondary to Ehlers-Danlos syndrome presenting as a case of asthma: a case report","volume":"164","author":"Alhabeeb","year":"2023","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0017","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/s41598-024-52368-x","article-title":"Mismatch between subjective and objective dysautonomia","volume":"14","author":"Novak","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.anai.2025.03.022_bib0018","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cjca.2023.04.003","article-title":"Cardiovascular considerations in the management of people with suspected long COVID","volume":"39","author":"Quinn","year":"2023","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0019","first-page":"61","article-title":"[Severe mast cell Activation Syndrome in a 15-year-old patient with an hypermobile Ehlers-Danlos syndrome]","volume":"73","author":"Daens","year":"2018","journal-title":"Rev Med Li\u00e8ge"},{"issue":"10","key":"10.1016\/j.anai.2025.03.022_bib0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect Dis (Lond)"},{"issue":"7","key":"10.1016\/j.anai.2025.03.022_bib0021","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/bcp.13578","article-title":"Can H2 -receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case report","volume":"84","author":"Allen","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.anai.2025.03.022_bib0022","series-title":"Symptomatic: The Symptom-Based Handbook for Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders","first-page":"375","article-title":"Feeling shaky with palpitations: hypertension, tachycardia, dizziness, and near syncope","author":"Grubb","year":"2024"},{"issue":"suppl 2","key":"10.1016\/j.anai.2025.03.022_bib0023","first-page":"S45","article-title":"Ehlers Danlos syndrome: who is affected and how they present","volume":"11","author":"Song","year":"2019","journal-title":"PM R"},{"issue":"suppl 14","key":"10.1016\/j.anai.2025.03.022_bib0024","first-page":"P1","article-title":"Evidence of mast cell activation disorder in postural tachycardia syndrome","volume":"84","author":"Hoffman-Snyder","year":"2015","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0025","first-page":"57","article-title":"Mast cell disorders-experience of a tertiary referral centre","volume":"181","author":"Wharin","year":"2018","journal-title":"Br J Haematol"},{"issue":"5)(suppl","key":"10.1016\/j.anai.2025.03.022_bib0026","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.anai.2018.09.273","article-title":"An index case of a rare form of inducible urticaria successfully treated with omalizumab","volume":"121","author":"Greiwe","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0027","doi-asserted-by":"crossref","first-page":"AB138","DOI":"10.1016\/j.jaci.2020.12.503","article-title":"Clinical significance of mast cell counts in patients presenting with mast cell disorders","volume":"147","author":"Zhang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0028","doi-asserted-by":"crossref","first-page":"34","DOI":"10.37757\/MR2021.V23.N2.10","article-title":"Genodermatoses in las tunas Province, Cuba, 1989-2019","volume":"23","author":"Velazquez-Avila","year":"2021","journal-title":"MEDICC Rev."},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0029","article-title":"Removal of polymer clips from the gallbladder fossa in a patient with Ehlers-Danlos syndrome (EDS) to treat mast cell activation syndrome (MCAS): a case report","volume":"15","author":"Xiao","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.anai.2025.03.022_bib0030","first-page":"545","article-title":"Efficacy of epidural blood patch as a treatment for chronic orthostatic intolerance: a case series","volume":"29","author":"Kinsella","year":"2019","journal-title":"Clin Auton Res"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0031","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1016\/j.jvs.2023.01.139","volume":"77","author":"Kim","year":"2023","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0032","doi-asserted-by":"crossref","first-page":"AB236","DOI":"10.1016\/j.jaci.2019.12.126","article-title":"Clinical features and response to treatment in patients with skin biopsies showing congenital connective tissue disorders","volume":"145","author":"Srivastava","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0033","doi-asserted-by":"crossref","first-page":"S1358","DOI":"10.14309\/00000434-201710001-02489","article-title":"Severe gastrointestinal dysmotility in patients with Ehlers-Danlos syndrome: case series-1 center experience","volume":"112","author":"Alomari","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.anai.2025.03.022_bib0034","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","article-title":"Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders","volume":"45","author":"Shibao","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.anai.2025.03.022_bib0035","article-title":"Mast cell activation syndrome (MCAS): symptom prevalence and characteristic of patients with this presumed diagnosis","volume":"16","author":"Shusterman","year":"2019","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0036","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijoa.2022.103488","article-title":"Elective caesarean section in a patient with mast cell activation syndrome","volume":"50","author":"O\u2019Brien","year":"2022","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.anai.2025.03.022_bib0037","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1542\/peds.144.2MA5.467","article-title":"Chiari malformation (CM) and\/or tethered cord, idiopathic mast cell activation syndrome (MCAS), Ehlers-Danlos syndrome (EDS), and postural orthostatic tachycardia syndrome (POTS): a new pediatric disease cluster","volume":"144","author":"Jackson","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0038","first-page":"47","article-title":"Increased prevalence of autonomic dysfunction due to postural orthostatic tachycardia syndrome in patients with eosinophilic gastrointestinal disorders","volume":"28","author":"Huang","year":"2019","journal-title":"J."},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0039","first-page":"27","article-title":"Mast cell activation syndrome or other?","volume":"16","author":"Neri","year":"2022","journal-title":"Ital J Med"},{"issue":"suppl 2","key":"10.1016\/j.anai.2025.03.022_bib0040","first-page":"A189","article-title":"Medication usage in hypermobile Ehlers-Danlos syndrome\/hypermobile spectrum disorder patients with concomitant disorders of Gutbrain interactions","volume":"72","author":"Upadhyaya","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0041","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/08998280.2020.1805714","article-title":"Systemic manifestations of Ehlers-Danlos syndrome","volume":"34","author":"Song","year":"2020","journal-title":"Bayl Univ Med Cent Proc"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0042","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.c.31940","article-title":"Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome\/hypermobility spectrum disorder","volume":"187","author":"Brock","year":"2021","journal-title":"Am J Med Genet C"},{"issue":"5","key":"10.1016\/j.anai.2025.03.022_bib0043","first-page":"502","article-title":"Ehlers-Danlos syndrome and mast cell activation syndrome in postural tachycardia syndrome: contributions to a sicker phenotype?","volume":"28","author":"Bourne","year":"2018","journal-title":"Clin Auton Res"},{"issue":"5)(suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0044","first-page":"S82","article-title":"Mast cell activation syndrome in postural tachycardia syndrome: a sicker phenotype?","volume":"15","author":"Bourne","year":"2018","journal-title":"Heart Rhythm"},{"issue":"2)(suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0045","doi-asserted-by":"crossref","first-page":"AB50","DOI":"10.1016\/j.jaci.2017.12.162","article-title":"Clinical characteristics of patients in allergy clinic with presumed diagnosis of mast cell activation syndrome (MCAS)","volume":"141","author":"Arndt","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2025.03.022_bib0047","first-page":"1590","article-title":"Familial hypermobile Ehlers-Danlos syndrome and comorbid dysautonomia may have a genetic neuroimmunologic origin","volume":"28","author":"Pace","year":"2019","journal-title":"J Womens Health"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0048","doi-asserted-by":"crossref","first-page":"AB182","DOI":"10.1016\/j.jaci.2018.12.558","article-title":"Prevalence of symptoms of mast cell activation in patients with postural orthostatic tachycardia syndrome and hypermobile Ehlers-Danlos syndrome","volume":"143","author":"Chang","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.03.022_bib0049","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/healthcare11060865","article-title":"A case study of successful application of the principles of ME\/CFS care to an individual with long COVID","volume":"11","author":"Petracek","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.anai.2025.03.022_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.668944","article-title":"Adolescent and young adult ME\/CFS after confirmed or probable COVID-19","volume":"8","author":"Petracek","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.anai.2025.03.022_bib0051","unstructured":"Lee D, Mueller E. Mast cell activation features in ehlers-danlos\/joint hypermobility patients: A retrospective analysis in light of an emerging disease cluster. Arthritis and Rheumatology. Acad R\/ARHP. Conference;Vol. 69: American College of Rheumatology\/Association of Rheumatology Health Professionals Annual Scientific Meeting; 2017."},{"issue":"5)(suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0052","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.anai.2017.09.016","article-title":"Multiple co-morbid conditions in patient with mast cell activation syndrome","volume":"119","author":"Szari","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl 2","key":"10.1016\/j.anai.2025.03.022_bib0053","doi-asserted-by":"crossref","first-page":"A188","DOI":"10.1016\/j.revmed.2019.10.283","article-title":"Efficacy of omalizumab in a series of 23 patients suffering from mast cell activating disorders","volume":"40","author":"Belbezier","year":"2019","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.anai.2025.03.022_bib0054","series-title":"Symptomatic: The Symptom-Based Handbook for Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders","first-page":"59","article-title":"Itchy rash and general malaise: multiple seemingly disparate symptoms, referable to mast cell activation syndrome (MCAS), a subtype of mast cell activation disease (MCAD)","author":"Maitland","year":"2024"},{"issue":"suppl 8","key":"10.1016\/j.anai.2025.03.022_bib0055","first-page":"499","article-title":"Quantifying the burden of food related allergic reactions in hypermobile Ehlers Danlos syndrome","volume":"10","author":"Topan","year":"2022","journal-title":"U Eur Gastroenterol J"},{"issue":"suppl 2","key":"10.1016\/j.anai.2025.03.022_bib0057","first-page":"A249","article-title":"When symptoms dictate a young person\u2019s life-and the importance of building trust and teamwork in rehabilitation of patients with complex conditions","volume":"104","author":"Gamper","year":"2019","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.anai.2025.03.022_bib0058","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjms.2019.03.005","article-title":"Recognition and management of medication excipient reactivity in patients with mast cell activation syndrome","volume":"357","author":"Schofield","year":"2019","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0059","first-page":"231","article-title":"Immunodeficiencies in Ehlers-Danlos syndrome: a case series of three patients","volume":"37","author":"Chau","year":"2017","journal-title":"J Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0060","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/annrheumdis-2021-eular.3177","article-title":"The relationship of mast cell activation syndrome and hypermobile Ehlers-Danlos syndrome in hospitalized patients in the united states","volume":"80","author":"Mathias","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"suppl","key":"10.1016\/j.anai.2025.03.022_bib0061","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jaclp.2023.11.675","article-title":"(207) Factitious disorder in pregnancy: when should you confront the patient?","volume":"64","author":"Karnik","year":"2023","journal-title":"J Acad Consult-Liaison Psychiatry"},{"issue":"5)(suppl","key":"10.1016\/j.anai.2025.03.022_bib0062","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.anai.2019.08.159","article-title":"Complex, persistent, multi-generational presentation of hereditary alpha tryptasemia syndrome requiring high dose omalizumab","volume":"123","author":"Paul","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl 18","key":"10.1016\/j.anai.2025.03.022_bib0063","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1212\/WNL.98.18_supplement.740","article-title":"Mast cell activation syndrome, mannose binding lectin, Ehlers-Danlos syndrome, and neuropsychiatric symptoms","volume":"98","author":"Ruhoy","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0064","doi-asserted-by":"crossref","first-page":"AB135","DOI":"10.1016\/j.jaci.2020.12.492","article-title":"The prevalence of hereditary alpha-tryptasemia in patients diagnosed with POTS via tilt table testing","volume":"147","author":"Huang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.03.022_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1369295","article-title":"Longitudinal cytokine and multi-modal health data of an extremely severe ME\/CFS patient with HSD reveals insights into immunopathology, and disease severity","volume":"15","author":"Jahanbani","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0066","first-page":"e203","article-title":"An unusual case of hot flashes in an athlete","volume":"32","author":"Caballero","year":"2022","journal-title":"Clin J Sport Med"},{"key":"10.1016\/j.anai.2025.03.022_bib0067","article-title":"Excessive dynamic airway collapse in a young woman with hypermobility-type Ehlers-Danlos syndrome","author":"Shah","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1016\/j.anai.2025.03.022_bib0068","article-title":"Persistent antiphospholipid antibodies, mast cell activation syndrome, postural orthostatic tachycardia syndrome and post-COVID syndrome: 1 year on","volume":"8","author":"Schofield","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.anai.2025.03.022_bib0069","first-page":"A12","article-title":"Prevalence of allergic disorders and mast cell activation syndrome in patients with Ehlers Danlos syndrome","volume":"1","author":"Louisias","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0070","first-page":"160","article-title":"Considerations for treatment of comorbid headaches and mast cell activation syndrome: a multidisciplinary team approach","volume":"61","author":"Reeves","year":"2021","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0071","first-page":"16","article-title":"Post-HPV-vaccination mast cell activation syndrome: possible vaccine-triggered escalation of undiagnosed pre-existing mast cell disease?","volume":"10","author":"Afrin","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.anai.2025.03.022_bib0072","first-page":"543","article-title":"A new disease cluster: postural tachycardia syndrome, hypermobile Ehlers-Danlos syndrome\/hypermobility spectrum disorder and mast cell activation syndrome","volume":"29","author":"Cheung","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.anai.2025.03.022_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1305972","article-title":"Characterizing a new clinical phenotype: the co-existence of cerebral venous outflow and connective tissue disorders","volume":"14","author":"Midtlien","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.anai.2025.03.022_bib0075","first-page":"36","article-title":"Complex presentations, identification and treatment of mast cell activation syndrome and associated conditions: a case report","volume":"22","author":"Quinn","year":"2023","journal-title":"Integr Med (Encinitas)"},{"issue":"5)(suppl","key":"10.1016\/j.anai.2025.03.022_bib0076","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.anai.2021.08.266","article-title":"Lifelong vibratory urticaria in a patient with postural orthostatic tachycardia syndrome and chronic abdominal pain","volume":"127","author":"Li","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0077","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/17423953221076984","article-title":"Gluten-free diet in postural orthostatic tachycardia syndrome (POTS)","volume":"19","author":"Zha","year":"2023","journal-title":"Chronic Illn"},{"issue":"5","key":"10.1016\/j.anai.2025.03.022_bib0078","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.anai.2019.08.427","article-title":"An innovative treatment approach to hereditary alpha-tryptasemia and interstitial cystitis","volume":"123","author":"Luskin","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0079","doi-asserted-by":"crossref","first-page":"261","DOI":"10.18176\/jiaci.0251","article-title":"Selective response to omalizumab in a patient with concomitant ncMCAS and POTS: what does it teach us about the underlying disease?","volume":"28","author":"Kacar","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0080","first-page":"S77","article-title":"Case Series of Severe Gastrointestinal Dysmotility in Ehlers-Danlos Syndrome (Eds). Discussion of Nutritional Management Roadmap. A BN","volume":"38","author":"Tremain-Hill","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.anai.2025.03.022_bib0081","first-page":"11","article-title":"Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment","volume":"11","author":"Weinstock","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.anai.2025.03.022_bib0082","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/jpm13111562","article-title":"Neuropsychiatric manifestations of mast cell activation syndrome and response to mast-cell-directed treatment: a case series","volume":"13","author":"Weinstock","year":"2023","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0083","first-page":"268","article-title":"Postural tachycardia syndrome (POTS) in migraine patients & their response to erenumab","volume":"39","author":"Robblee","year":"2019","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0084","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.hrthm.2023.09.012","article-title":"Postural orthostatic tachycardia syndrome after COVID-19 vaccination","volume":"21","author":"Teodorescu","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.anai.2025.03.022_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2022.08.601","article-title":"Ehlers-Danlos syndrome is associated with mast cell activation syndrome and chronic urticaria","volume":"129","author":"Walsh","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl 105","key":"10.1016\/j.anai.2025.03.022_bib0086","first-page":"764","article-title":"Association of stiff person syndrome with anti GAD antibodies with immune dysregulation and symptoms of mast cell activation syndrome","volume":"73","author":"Dubuske","year":"2018","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.03.022_bib0087","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/HJH.0000000000003669","article-title":"Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome","volume":"42","author":"Gonzalez-Alvarez","year":"2024","journal-title":"J Hypertens"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.03.022_bib0088","first-page":"S269","article-title":"Small fiber neuropathy pots and Gottron sign is COVID19 the culprit","volume":"36","author":"Alharbi","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0089","first-page":"727","article-title":"Comprehensive assessment of nutrition and dietary influences in hypermobile Ehlers-Danlos syndrome-a cross-sectional study","volume":"119","author":"Topan","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anai.2025.03.022_bib0090","doi-asserted-by":"crossref","first-page":"AB65","DOI":"10.1016\/j.jaci.2014.12.1146","article-title":"A new disease cluster: mast cell activation syndrome, postural orthostatic tachycardia syndrome, and Ehlers-Danlos syndrome","volume":"1","author":"Cheung","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.03.022_bib0091","first-page":"A87","article-title":"Mast cellactivation syndrome: likely diagnosis in an adolescent and her family with elevated tryptase and postural tachycardia syndrome [pots]","volume":"5","author":"Sprunger","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.03.022_bib0092","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.anai.2020.08.015","article-title":"Cosegregation of postural orthostatic tachycardia syndrome, hypermobile Ehlers-Danlos syndrome, and mast cell activation syndrome","volume":"125","author":"Vadas","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.03.022_bib0093","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2500\/aap.2021.42.210022","article-title":"The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome","volume":"42","author":"Wang","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2025.03.022_bib0094","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3934\/Allergy.2022004","article-title":"The gastrointestinal effects amongst Ehlers-Danlos syndrome, mast cell activation syndrome and postural orthostatic tachycardia syndrome","volume":"6","author":"Wong","year":"2022","journal-title":"AIMS Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.03.022_bib0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.iac.2018.04.004","article-title":"Association of postural tachycardia syndrome and Ehlers-Danlos syndrome with mast cell activation disorders","volume":"38","author":"Bonamichi-Santos","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0096","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09687599.2024.2345346","article-title":"Navigating environmental academia in a disabled body: an embodied autoethnography of ableism and advocacy","volume":"40","author":"Bromser-Kloeden","year":"2025","journal-title":"Disabil Soc"},{"issue":"5","key":"10.1016\/j.anai.2025.03.022_bib0097","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2044.1984.tb07313.x","article-title":"Anaesthesia and severe skin disease","volume":"39","author":"Smith","year":"1984","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.anai.2025.03.022_bib0098","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ajmg.c.31944","article-title":"Some cases of hypermobile Ehlers-Danlos syndrome may be rooted in mast cell activation syndrome","volume":"187","author":"Afrin","year":"2021","journal-title":"Am J Med Genet C"},{"key":"10.1016\/j.anai.2025.03.022_bib0099","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-030-62263-3_20","article-title":"The postural tachycardia syndrome (POTS)","author":"Mathias","year":"2021","journal-title":"Auton Nerv Syst Sleep Order Disorder"},{"issue":"12","key":"10.1016\/j.anai.2025.03.022_bib0100","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14031","article-title":"Mechanisms and management of gastrointestinal symptoms in postural orthostatic tachycardia syndrome","volume":"32","author":"Tu","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0101","article-title":"Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders","volume":"3","author":"Vazquez","year":"2022","journal-title":"HGG Adv"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0102","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaip.2023.10.043","article-title":"Hereditary alpha-tryptasemia in patients with postural orthostatic tachycardia syndrome","volume":"12","author":"Huang","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.03.022_bib0103","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.03.022_bib0104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/dx-2020-0005","article-title":"Diagnosis of mast cell activation syndrome: a global \u201cconsensus-2\u201d","volume":"8","author":"Afrin","year":"2021","journal-title":"Diagnosis (Berl)"},{"issue":"1","key":"10.1016\/j.anai.2025.03.022_bib0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2024.09.006","article-title":"Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome criteria","volume":"155","author":"Solomon","year":"2025","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T09:54:04Z","timestamp":1750931644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1081120625001589"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.03.022","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of mast cell activation disorders and hereditary alpha tryptasemia among patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}